Insulin resistance (IR) contributes to the pathophysiology of diabetes, dementia, viral infection, and cardiovascular disease. Drug repurposing (DR) may identify treatments for IR; …
J Li, H Xu, RA McIndoe - PloS one, 2022 - journals.plos.org
Drug combination therapies can improve drug efficacy, reduce drug dosage, and overcome drug resistance in cancer treatments. Current research strategies to determine which drug …
X Li, EK Dowling, G Yan, Z Dereli, B Bozorgui… - Cancer discovery, 2022 - AACR
Cancer cells depend on multiple driver alterations whose oncogenic effects can be suppressed by drug combinations. Here, we provide a comprehensive resource of precision …
Drugs used in combination can synergize to increase efficacy, decrease toxicity, and prevent drug resistance. While conventional high-throughput screens that rely on univariate data are …
Y Shim, M Lee, PJ Kim, HG Kim - BMC bioinformatics, 2022 - Springer
Background To reduce drug side effects and enhance their therapeutic effect compared with single drugs, drug combination research, combining two or more drugs, is highly important …
For large libraries of small molecules, exhaustive combinatorial chemical screens become infeasible to perform when considering a range of disease models, assay conditions, and …
Tumour heterogeneity is one of the main characteristics of cancer and can be categorised into inter‐or intratumour heterogeneity. This heterogeneity has been revealed as one of the …
L Frusciante, A Visibelli, M Geminiani… - Current Topics in …, 2022 - ingentaconnect.com
The role of computational tools in the drug discovery and development process is becoming central, thanks to the possibility to analyze large amounts of data. The high throughput and …
Drugs not only perturb their immediate protein targets but also modulate multiple signaling pathways. In this study, we explored networks modulated by several drugs across multiple …